Last seen: Sep 21, 2025
Starting research on time in industry is realistic, but fully completing research on time is less realistic. The deadlines in industry are often there...
I do agree with the next step for pre-clinical research before testing on humans is the substitution of animal testing with computer simulations, but ...
The choice between novel and tested materials ultimately comes down to balancing the benefits versus the risks a company is willing to take to gain fr...
Over-planning sounds like it would lead to a more straight-forward project, however it could complicate risk management processes. While meticulous pl...
As you mentioned, projects may not go exactly as planned, especially in medical device projects. A lack of organization can mean that a project fails ...
I would say that the biggest obstacle in projects is making sure everyone does their fair share of work. Disagreements can be solved through discussio...
For transitioning between careers within BME, I would think that it is harder to transition from academia to industry, than from industry to academia....
I believe that a successful professor should have some experience in industry, however successful can be defined by different definitions. For a profe...
For an improvement in the industry, I think the use of AI is showing signs that is is helping accelerate progress in medicine. On the news, I read abo...
As mentioned previously, there are different stages to recalls; each one being more severe than the other. The FDA can inform the company on a strateg...
The cheap aspect of fast-good-cheap is one topic that may be up for discussion. More specifically, much of the financial aspects of developing a vacci...
Certain jurisdictions allow for streamlined product approval by using clinical data obtained from other jurisdictions. This is called a data-reliance ...
Assuming that once a smaller companies has identified a suitable clinical trial management company to contract with, payment could become a key part i...
One factor which can make or break communication within a clinical trial and project is communication latency. The time from delivery to acknowledgeme...
One reason that a company may want to outsource their clinical trials is for scalability reasons. With small companies, a limiting factor for clinical...